Skip to main content

Table 3 Allele and genotype frequencies of SNVs in preeclamptics and controls

From: MTHFR and F5 genetic variations have association with preeclampsia in Pakistani patients: a case control study

SNV

Genetic model/ HWE (p)

Allele/Genotype

Cases n (%)

Controls

n (%)

OR (95%CI)

p-value

P*

F5:c.1601G > A

 

G

246 (98)

249 (99.6)

1.00

0.2125

0.35

A

04 (2)

01 (0.4)

4.05 (0.45–36.48)

N/A

G/G

121 (96.8)

124 (99.2)

1.00

0.16

0.28

G/A

4 (3.2)

1 (0.8)

4.10 (0.45–37.16)

 

HWE (p)

–

0.85

0.96

–

–

 

F5:c.6665A > G

 

A

232 (93)

219 (88)

1.00

0.0532

0.099

G

18 (7)

31 (12)

0.55 (0.30–1.00)

Codominant

A/A

109 (87.2)

95 (76)

1.00

0.036

0.077

A/G

14 (11.2)

29 (23.2)

0.42 (0.21–0.84)

G/G

2 (1.6)

1 (0.8)

1.74 (0.16–19.53)

Dominant

A/A

109 (87.2)

95 (76)

1.00

0.021

0.053

A/G-G/G

16 (12.8)

30 (24)

0.46 (0.24–0.90)

Recessive

A/A-A/G

123 (98.4)

124 (99.2)

1.00

0.56

0.71

G/G

2 (1.6)

1 (0.8)

2.02 (0.18–22.53)

Overdominant

A/A-G/G

111 (88.8)

96 (76.8)

1.00

0.011

0.038

A/G

14 (11.2)

29 (23.2)

0.42 (0.21–0.84)

Log- additive

–

–

–

0.55 (0.30–1.02)

0.052

0.104

 

HWE (p)

–

0.12

0.69

–

–

 

MTHFR:c.665C > T

 

C

224 (90)

240 (96)

1.00

0.0076

0.0425

T

26 (10)

10 (4)

2.78 (1.31–5.90)

Codominant

C/C

102 (81.6)

116 (92.8)

1.00

0.026

0.06

C/T

20 (16)

8 (6.4)

2.84 (1.20–6.73)

T/T

3 (2.4)

1 (0.8)

3.41 (0.35–33.32)

 

Dominant

C/C

102 (81.6)

116 (92.8)

1.00

0.0071

0.0497

C/T-T/T

23 (18.4)

9 (7.2)

2.91 (1.29–6.57)

Recessive

C/C-C/T

122 (97.6)

124 (99.2)

1.00

0.3

0.42

T/T

3 (2.4)

1 (0.8)

3.05 (0.31–29.72)

Overdominant

C/C-T/T

105 (84)

117 (93.6)

1.00

0.015

0.046

C/T

20 (16)

8 (6.4)

2.79 (1.18–6.59)

Log- additive

–

–

–

2.48 (1.20–5.13)

0.0085

0.0396

 

HWE (p)

–

0.12

0.17

–

–

 

MTHFR:c.1286A > C

 

A

168 (67)

132 (53)

1.00

0.0011

0.0308

C

82 (33)

118 (47)

0.55 (0.38–0.78)

Codominant

A/A

61 (48.8)

40 (32)

1.00

0.0098

0.0392

A/C

46 (36.8)

52 (41.6)

0.58 (0.33–1.02)

C/C

18 (14.4)

33 (26.4)

0.36 (0.18–0.72)

Dominant

A/A

61 (48.8)

40 (32)

1.00

0.0066

0.0616

A/C-C/C

64 (51.2)

85 (68)

0.49 (0.30–0.83)

Recessive

A/A-A/C

107 (85.6)

92 (73.6)

1.00

0.018

0.0503

C/C

18 (14.4)

33 (26.4)

0.47 (0.25–0.89)

Overdominant

A/A-C/C

79 (63.2)

73 (58.4)

1.00

0.44

0.58

A/C

46 (36.8)

52 (41.6)

0.82 (0.49–1.36)

Log -additive

–

–

–

0.60 (0.42–0.84)

0.0024

0.0336

 

HWE (p)

–

0.069

0.073

–

–

 

VEGFA: c.-2055A > C

 

C

138 (55)

135 (54)

1.00

0.7876

0.8821

A

112 (45)

115 (46)

0.95 (0.67–1.35)

Codominant

C/C

36 (28.8)

35 (28)

1.00

0.95

0.95

A/C

66 (52.8)

65 (52)

0.99 (0.55–1.76)

A/A

23 (18.4)

25 (20)

0.89 (0.43–1.86)

Dominant

C/C

36 (28.8)

35 (28)

1.00

0.89

0.958

A/C-A/A

89 (71.2)

90 (72)

0.96 (0.55–1.67)

Recessive

C/C-A/C

102 (81.6)

100 (80)

1.00

0.75

0.91

A/A

23 (18.4)

25 (20)

0.90 (0.48–1.69)

Overdominant

C/C-A/A

59 (47.2)

60 (48)

1.00

0.9

0.93

A/C

66 (52.8)

65 (52)

1.03 (0.63–1.70)

Log- additive

–

–

–

0.95 (0.66–1.37)

0.78

0.91

 

HWE (p)

–

0.59

0.72

–

–

 

VEGFA:c.*237C > T

 

C

229 (92)

222 (89)

1.00

0.2939

0.433

T

21 (8)

28 (11)

0.73 (0.40–1.32)

N/A

C/C

104 (83.2)

97 (77.6)

1.00

0.26

0.404

C/T

21 (16.8)

28 (22.4)

0.70 (0.37–1.31)

 

HWE (p)

–

0.305

0.36

–

–

 
  1. HWE hardy-weinberg equilibrium; P*: Benjamini-Hochberg adjusted P value. Bold fonts indicate significant P-value